Examol is developing an integrated data, method and workflow platform for computational drug discovery in the small molecule space. Their cloud-native solution consists of a molecule database ready for AI-scale data ingress and egress, with modern UI and API. Combined with powerful add-ons and workflow orchestration, they offer barrier-free access to standard methodologies in computational chemistry, novel AI, and physics methods, easy to run at scale in the Cloud or customers’ premises. They aim to centralize data from computational chemistry calculations, automate & streamline intricate workflows to enhance productivity, access to innovation and data reliability for drug discovery companies.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Pittsburgh, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://examol.io
- Keywords
- Computational Drug Discovery, Quantum Chemistry, Infrastructure, SaaS, B2B, Machine Learning, Artificial Intelligence, Similarity Search, Molecular Database, Molecular Dynamics, Pipeline.
- HQ
- Pittsburgh
Examol Questions
Examol's website is https://examol.io
Examol's LinkedIn profile is https://www.linkedin.com/company/examol
Examol has
5 employees.
View email and phone details for 5
employees at Examol.
Examol's industry is
Biotechnology Research
Examol's top competitors are
Sunar Tech Solutions,
Magic,
Blueprint,
Xaira Therapeutics,
Tangible,
Roivant,
Exact Sciences,
Performance Software Corporation,
Berkley Hunt,
Sandboxaq.
Examol's categories are Biotechnology Research
Examol's founding year is 2023
